Physician profile
Tejas Raval
NPI 1992827356
$5,969.37
in general payments reported to CMS, 2019-2025
18 companies · $738 in 2025
The $738 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $57.16 · 2021: $33.00 · 2022: $90.02 · 2023: $1,609 · 2024: $3,238 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,677 · Travel and Lodging: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,677.35 |
| Travel and Lodging | $907.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $4,445.40 | 2023-2025 | Inspire |
| Aerin Medical INC. | $469.20 | 2022-2024 | |
| Medtronic, INC. | $238.40 | 2023-2025 | Sinuva, Stealthstation S8 Platform, Signia |
| Regeneron Healthcare Solutions, INC. | $140.25 | 2020-2024 | Dupixent |
| Hologic Sales and Service, LLC | $130.38 | 2024 | Coolseal Generator |
| Mallinckrodt Enterprises LLC | $123.75 | 2019 | |
| Genzyme Corporation | $121.59 | 2025 | |
| Olympus America INC. | $83.79 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $36.31 | 2021-2022 | |
| Phadia US INC. | $34.03 | 2019-2020 | |
| Intersect Ent, INC. | $29.86 | 2019 | |
| Karl Storz Endoscopy-America | $20.59 | 2019 | |
| Alk-Abello, INC | $19.76 | 2022 | |
| Tactile Systems Technology INC | $18.52 | 2020 | |
| Smith+Nephew, INC. | $17.58 | 2024 | Halo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $15.78 | 2023 | Nasopore |
| Integra Lifesciences Corporation | $12.55 | 2021 | |
| Snap Diagnostics LLC | $11.63 | 2023 | Snap Diagnostics Study |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tejas Raval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.